Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum

Journal of Virological Methods

Volumn 187, Issue 2, 2013, Pages 362-367

  Jin, Jun ^a   Ma, Hongxia ^b   Xu, Lin ^a   An, Dong ^a   Sun, Shiyang ^a   Huang, Xueyong ^b   Kong, Wei ^a   Jiang, Chunlai ^a  

^a JILIN UNIVERSITY   (China)

^b HENAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Coxsackievirus A16; Luciferase; Neutralizing antibody assay; Pseudovirus

Indexed keywords

LUCIFERASE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; COXSACKIE VIRUS A; EMBRYO; ENZYME ASSAY; GENE SEQUENCE; HUMAN; HUMAN CELL; INOCULATION; MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; VALIDATION PROCESS; VIRUS DETECTION; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE, TUMOR; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; ENTEROVIRUS; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INFANT; LUCIFERASES; NEUTRALIZATION TESTS; SERUM;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS 71;

EID: 84872681676     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.11.014     Document Type: Article

References (33)

1. Ang L.W., Koh B.K., Chan K.P., Chua L.T., James L., Goh K.T. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann. Acad. Med. Singapore 2009, 38:106-112.
2. Arita M., Ami Y., Wakita T., Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 2008, 82:1787-1797.
3. Bartosch B., Bukh J., Meunier J.C., Granier C., Engle R.E., Blackwelder W.C., Emerson S.U., Cosset F.L., Purcell R.H. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14199-14204.
4. Chang L.Y., King C.C., Hsu K.H., Ning H.C., Tsao K.C., Li C.C., Huang Y.C., Shih S.R., Chiou S.T., Chen P.Y., Chang H.J., Lin T.Y. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics 2002, 109:e88.
5. Chang L.Y., Lin T.Y., Huang Y.C., Tsao K.C., Shih S.R., Kuo M.L., Ning H.C., Chung P.W., Kang C.M. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr. Infect. Dis. J. 1999, 18:1092-1096.
6. Chen L., Mou X., Zhang Q., Li Y., Lin J., Liu F., Yuan L., Tang Y., Xiang C. Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China. Mol. Med. Rep. 2012, 5:1001-1004.
7. Cooper D.J., Shaw D.R., LaBrooy J.T., Blumbergs P., Gilbert J., Simmons A. Fatal rhabdomyolysis and renal failure associated with hand, foot and mouth disease. Med. J. Aust. 1989, 151:232-234.
8. Fukushi S., Mizutani T., Saijo M., Kurane I., Taguchi F., Tashiro M., Morikawa S. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J. Med. Virol. 2006, 78:1509-1512.
9. Horodniceanu F., Panon G., Le Fur R., Barme M. Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose. Dev. Biol. Stand. 1979, 42:75-80.
10. Hosoya M., Kawasaki Y., Sato M., Honzumi K., Hayashi A., Hiroshima T., Ishiko H., Kato K., Suzuki H. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J. Clin. Microbiol. 2007, 45:112-120.
11. Keck Z.Y., Li T.K., Xia J., Bartosch B., Cosset F.L., Dubuisson J., Foung S.K. Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2. J. Virol. 2005, 79:13199-13208.
12. Kobinger G.P., Figueredo J.M., Rowe T., Zhi Y., Gao G., Sanmiguel J.C., Bell P., Wivel N.A., Zitzow L.A., Flieder D.B., Hogan R.J., Wilson J.M. Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques. Vaccine 2007, 25:5220-5231.
13. Kung S.H., Wang S.F., Huang C.W., Hsu C.C., Liu H.F., Yang J.Y. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin. Microbiol. Infect. 2007, 13:782-787.
14. Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatr. Infect. Dis. J. 2009, 28:904-910.
15. Li L., He Y., Yang H., Zhu J., Xu X., Dong J., Zhu Y., Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J. Clin. Microbiol. 2005, 43:3835-3839.
16. Montefiori D.C. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. 2005, 12.11.1-12.11.17.
17. Motulsky H., Christopoulos A. Fitting Models to Biological Data Using Linear and Nonlinear Regression. A Practical Guide to Curve Fitting 2004, Oxford University Press, New York.
18. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., Roundtree S., Thomas D.L., McKeating J., Cox A. Humoral immune response in acute hepatitis C virus infection. Clin. Infect. Dis. 2005, 41:667-675.
19. Perera D., Yusof M.A., Podin Y., Ooi M.H., Thao N.T., Wong K.K., Zaki A., Chua K.B., Malik Y.A., Tu P.V., Tien N.T., Puthavathana P., McMinn P.C., Cardosa M.J. Molecular phylogeny of modern coxsackievirus A16. Arch. Virol. 2007, 152:1201-1208.
20. Rabenau H.F., Richter M., Doerr H.W. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med. Microbiol. Immunol. 2010, 199:45-51.
21. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
22. Solomon, Lewthwaite T., Perera P., Cardosa D., McMinn M.J., Ooi P., Virology M.H. Epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10:778-790.
23. Tamin A., Harcourt B.H., Lo M.K., Roth J.A., Wolf M.C., Lee B., Weingartl H., Audonnet J.C., Bellini W.J., Rota P.A. Development of a neutralization assay for Nipah virus using pseudotype particles. J. Virol. Methods 2009, 160:1-6.
24. Temperton N.J., Chan P.K., Simmons G., Zambon M.C., Tedder R.S., Takeuchi Y., Weiss R.A. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg. Infect. Dis. 2005, 11:411-416.
25. Troupin C., Dehee A., Schnuriger A., Vende P., Poncet D., Garbarg-Chenon A. Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses. J. Virol. 2010, 84:6711-6719.
26. Wang C.Y., Li Lu F., Wu M.H., Lee C.Y., Huang L.M. Fatal coxsackievirus A16 infection. Pediatr. Infect. Dis. J. 2004, 23:275-276.
27. Wang W., Butler E.N., Veguilla V., Vassell R., Thomas J.T., Moos M., Ye Z., Hancock K., Weiss C.D. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J. Virol. Methods 2008, 153:111-119.
28. Wong S.S., Yip C.C., Lau S.K., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 2010, 138:1071-1089.
29. Wright E., Temperton N.J., Marston D.A., McElhinney L.M., Fooks A.R., Weiss R.A. Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J. Gen. Virol. 2008, 89:2204-2213.
30. Yip C.C., Lau S.K., Zhou B., Zhang M.X., Tsoi H.W., Chan K.H., Chen X.C., Woo P.C., Yuen K.Y. Emergence of enterovirus 71 double-recombinant strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch. Virol. 2010, 155:1413-1424.
31. Zhang H.M., Li C.R., Liu Y.J., Liu W.L., Fu D., Xu L.M., Xie J.J., Tan Y., Wang H., Chen X.C., Zhou B.P. To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009, 23:334-336.
32. Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A., Yan D., Li Q., Dong X., Zhang J., Zhao Y., Wan J., Feng Z., Sun J., Wang S., Li D., Xu W. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 2010, 7:94.
33. Zhou F., Kong F., Wang B., McPhie K., Gilbert G.L., Dwyer D.E. Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region. J. Med. Microbiol. 2010, 60:349-358.